Skip to main content

COVID-19 Vaccine AstraZeneca (ChAdOx1-S) solution for injection 5mL multidose vial, AstraZeneca Pty Ltd, CON-754

Product name
COVID-19 Vaccine AstraZeneca (ChAdOx1-S) solution for injection 5mL multidose vial
Sponsor name
AstraZeneca Pty Ltd
ARTG
349072
Consent start
Consent no.
CON-754
Standard
Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The product does not comply with TGO 91.
Conditions imposed
          The product must be supplied with the labels that were considered and agreed to as part of the evaluation under section 25 of the Therapeutic Goods Act 1989, being      a) The international label, referred to here as 'EU labels' for 10 doses per vial, as follows     i. Carton label   ii. Vial label iii. Stickers    
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site